Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI Tool Outperforms Human Pathologists in Predicting Survival after Colorectal Cancer Diagnosis

By HospiMedica International staff writers
Posted on 14 Apr 2023

Colorectal cancer, the second most lethal cancer worldwide, exhibits varying behavior even among individuals with similar disease profiles who undergo the same treatment. More...

Now, a new artificial intelligence (AI) model may now offer valuable insight to doctors making prognoses and determining treatments for patients with colorectal cancer.

Researchers at Harvard Medical School (Boston, MA, USA) and National Cheng Kung University (Tainan, Taiwan) have developed a tool called MOMA (Multi-omics Multi-cohort Assessment) that accurately predicts colorectal tumor aggressiveness, patient survival rates with and without disease recurrence, and the most effective therapy by analyzing tumor sample images alone. Unlike many existing AI tools that primarily replicate or optimize human expertise, MOMA identifies and interprets visual patterns on microscopy images that are undetectable to the human eye. The tool is freely available to researchers and clinicians.

The model was trained using data from approximately 2,000 colorectal cancer patients from diverse national patient cohorts, totaling over 450,000 participants. During training, researchers provided the model with information about patients' age, sex, cancer stage, and outcomes, as well as genomic, epigenetic, protein, and metabolic profiles of the tumors. The model was then tasked with identifying visual markers related to tumor types, genetic mutations, epigenetic changes, disease progression, and patient survival using pathology images of tumor samples. The model's performance was assessed using a set of previously unseen tumor sample images from different patients, comparing its predictions to actual patient outcomes and other clinical data.

MOMA accurately predicted overall survival following diagnosis and the number of cancer-free years for patients. It also correctly anticipated individual patient responses to various therapies based on the presence of specific genetic mutations influencing cancer progression or spread. In both areas, the tool outperformed human pathologists and current AI models. The researchers recommend testing the model in a prospective, randomized trial evaluating its performance in real patients over time after initial diagnosis before deploying it in clinics and hospitals. Such a study would directly compare MOMA's real-life performance using only images with human clinicians who utilize additional knowledge and test results unavailable to the model, providing the gold-standard demonstration of its capabilities.

“Our model performs tasks that human pathologists cannot do based on image viewing alone,” said study co-senior author Kun-Hsing Yu, assistant professor of biomedical informatics in the Blavatnik Institute at Harvard Medical School, who led an international team of pathologists, oncologists, biomedical informaticians, and computer scientists. “What we anticipate is not a replacement of human pathology expertise, but augmentation of what human pathologists can do. We fully expect that this approach will augment the current clinical practice of cancer management.”

Related Links:
Harvard Medical School
National Cheng Kung University


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Resorbable Bovine Collagen Membrane
GenDerm
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.